Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding

This publication has 40 references indexed in Scilit:

• Rectal morbidity after permanent interstitial brachytherapy for prostate cancer—Impact of Day 1 vs. Day 30 computed tomography–based postimplant dosimetry
  Brachytherapy, 2010
• Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer
  European Urology, 2009
• Factor Analysis of the Expanded Prostate Cancer Index Composite in a Patient Group after Primary (External Beam Radiotherapy and Permanent Iodine-125 Brachytherapy) and Postoperative Radiotherapy for Prostate Cancer
  Current Urology, 2009
• Update of Dutch Multicenter Dose-Escalation Trial of Radiotherapy for Localized Prostate Cancer
  International Journal of Radiation Oncology*Biology*Physics, 2008
• Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking
  Radiation Oncology, 2008
• High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients
  Radiation Oncology, 2008
• Late Gastrointestinal Morbidity After Three-Dimensional Conformal Radiation Therapy for Prostate Cancer Fades With Time in Contrast to Genitourinary Morbidity
  International Journal of Radiation Oncology*Biology*Physics, 2008
• Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy
  Journal of Clinical Oncology, 2006
• Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV
  International Journal of Radiation Oncology*Biology*Physics, 2004
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
  Seminars in Radiation Oncology, 2003